Chronic headache sufferers may benefit from adjuvant drugs, devices and procedures
Experts weigh in on the amyloid hypothesis and how to use lecanemab if approved
Initial pilot study findings suggest a potential reduced need for cerebrospinal fluid testing
Intracranial injection of supercharged immune cells proceeds to phase 2 testing
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Multidisciplinary efforts to refine cerebral hemodynamic goals in a high-risk population
A comprehensive, measured approach is key to long-term management
Medication-focused intervention key to management success in a challenging population
Two complex conditions with clinical and diagnostic similarities
Virtual care, shared appointments and a team-based approach help expand access
Gait becomes more normalized along with gains in speed
Advertisement
Advertisement